Avalo Therapeutics (AVTX) Current Assets (2014 - 2026)
Avalo Therapeutics (AVTX) reported Current Assets of $407.93 million for Q2 2026, up 254.2% from $115.19 million a year earlier and up 359.3% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Avalo Therapeutics posted Current Assets of $105.29 million, down 24.2% from FY2024.
- Current Assets has a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
- By year, Current Assets came in at $138.89 million in FY2024, $8.4 million in FY2023 (-48.9%), $16.42 million in FY2022 (-73.5%) and $61.85 million in FY2021 (+137.8%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets in data going back to Q4 2014.
- Year over year, Current Assets gained in five of the last seven quarters, with growth averaging 121.0%.
- The high point for year-over-year Current Assets in five years was Q3 2024 (growth of 580.5%); the low point was Q3 2022 (a decline of 74.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $88.83 million (Q1 2026), $105.29 million (Q4 2025) and $113.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - | 407.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 407.93 Mn |
| Mar 31, 2026 | 88.83 Mn |
| Dec 31, 2025 | 105.29 Mn |
| Sep 30, 2025 | 113.85 Mn |
| Jun 30, 2025 | 115.19 Mn |
| Mar 31, 2025 | 126.94 Mn |
| Dec 31, 2024 | 138.89 Mn |
| Sep 30, 2024 | 86.15 Mn |
| Jun 30, 2024 | 95.89 Mn |
| Mar 31, 2024 | 111.21 Mn |
| Dec 31, 2023 | 8.40 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 7.52 Mn |
| Mar 31, 2023 | 19.25 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 19.45 Mn |
| Jun 30, 2022 | 15.02 Mn |
| Mar 31, 2022 | 43.66 Mn |
| Dec 31, 2021 | 61.85 Mn |
| Sep 30, 2021 | 77.01 Mn |
API Access
Avalo Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();